2m 2m 2m 2m 2m 2m 2m
DIAMEDICA THERAP (DMAC)
NASDAQ
$6.33-$0.010 (-0.16%)
Price as of Jul 31, 2026 4:10 PM EDT- $341.6MMarket Cap
- 53.88%1-Year Change
- BiotechnologyIndustry
DIAMEDICA THERAP (DMAC)
$6.33-$0.010 (-0.16%)
DMAC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.34 | ||
Change | -$0.17 (-2.61%) | ||
Open | $6.54 | ||
High | $6.54 | ||
Low | $6.26 | ||
Previous Close | $6.51 | ||
Volume | 99,023 | ||
30-Day Average Volume | 215,241 | ||
1-Week Change | -5.86% | ||
1-Month Change | -9.94% | ||
1-Year Change | 53.88% | ||
3-Year Change | 87.57% | ||
5-Year Change | 83.77% | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $53.1M | ||
Market Cap | $341.6M | ||
Enterprise Value | $336.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $46.6M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -33 | ||
PEG | 2 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue